Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation
February 01, 2024 03:00 ET
|
Cumulus Oncology
Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation Newly appointed CEO, Dr Xavier Leroy, will...
Cumulus Oncology raises £9m in seed financing
January 08, 2024 02:00 ET
|
Cumulus Oncology
Cumulus Oncology raises £9m in seed financing Eos Advisory-led round includes new corporate investor the Scottish National Investment Bank Proceeds from the financing will be used to support Cumulus...
Cumulus Oncology and leadXpro Announce Collaboration to Develop Small Molecules against Novel Cancer-Focused GPCR Targets
July 17, 2023 02:00 ET
|
Cumulus Oncology
Cumulus Oncology and leadXpro Announce Collaboration to Develop Small Molecules against Novel Cancer-Focused GPCR Targets Resulting IP will be licensed into a newly created Cumulus company ...
LDC and Cumulus Oncology announce collaboration
March 22, 2021 04:00 ET
|
Cumulus Oncology
LDC and Cumulus Oncology announce collaboration Dortmund, Germany, and Edinburgh, Scotland, March 22nd, 2021. The Lead Discovery Center GmbH (LDC) and Cumulus Oncology announce the signing of a...
Modulus Oncology Appoints Tim Edwards as Chairman
January 11, 2021 07:00 ET
|
Modulus Oncology
Modulus Oncology Appoints Tim Edwards as Chairman Sheffield, UK, 11 January 2021: Modulus Oncology, a new and rapidly emerging private biotech company focused on treating hard-to-treat cancers,...
Modulus Oncology Appoints Tim Edwards as Chairman
January 11, 2021 02:00 ET
|
Modulus Oncology
Modulus Oncology Appoints Tim Edwards as Chairman Sheffield, UK, 11 January 2021: Modulus Oncology, a new and rapidly emerging private biotech company focused on treating hard-to-treat cancers,...
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers
September 09, 2020 02:00 ET
|
Modulus Oncology
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers First-in-class drug blocks key signals required for tumour growth and metastasisHighly...